Platform
Company
Body Fluids
Review status
Currently under review
Pending specialist review and validation.
CSF glycine measures the amount of the amino acid glycine in your cerebrospinal fluid, the clear liquid that bathes the brain and spinal cord. Glycine functions as a building block of proteins and as a neurotransmitter that helps regulate nerve signaling. Measuring it in CSF provides a direct view of brain chemistry that cannot be reliably inferred from blood alone.
The sample is collected during a lumbar puncture performed by a trained clinician. In the laboratory, glycine is quantified using specialized techniques such as chromatography or mass spectrometry, either as part of a broader amino acid analysis or as a targeted measurement.
This test helps evaluate suspected disorders of glycine metabolism and transport, including a condition often called nonketotic hyperglycinemia, and can support the assessment of other neurometabolic or mitochondrial disorders. It may be ordered when there are neurologic symptoms such as difficult to control seizures, reduced alertness, poor muscle tone, or unexplained developmental concerns.
Results can guide diagnosis, determine whether additional metabolic or genetic testing is needed, and inform treatment strategies such as seizure management or targeted metabolic therapies. It is not a routine screening test and is usually requested by specialists after a careful clinical evaluation.
Your clinician will interpret your result alongside your symptoms, examination findings, and other laboratory studies. Patterns in CSF amino acids, the relationship between CSF and blood glycine, and results from urine organic acids or metabolic panels are often considered together to understand the cause of neurologic signs.
If your level suggests a disorder of glycine metabolism, your care team may recommend confirmatory testing, such as plasma amino acids, molecular testing of genes involved in the glycine cleavage system, or repeat sampling if preanalytic issues are suspected. If results are within the expected range yet symptoms persist, your clinician may investigate other causes. Ask how and when you will receive results, and what the next steps will be for follow-up and care.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Delayed processing or improper storage of CSF can alter amino acid stability. Prompt separation and rapid freezing, followed by transport on cold packs or dry ice, help preserve an accurate glycine measurement.
A traumatic lumbar puncture that introduces blood into the CSF can affect amino acid levels and complicate interpretation. Your clinician and the lab will note specimen appearance and may use the least blood-contaminated tube.
High protein intake, prolonged fasting, fever, or catabolic stress can shift amino acid metabolism. Let your clinician know about recent illness, diet changes, or supplements so results can be interpreted correctly.
Treatments such as sodium benzoate, dextromethorphan, certain anticonvulsants, or amino acid supplements may influence glycine metabolism or measurement. Provide a complete medication list, including over-the-counter products.
Conditions that disrupt the blood–brain barrier, such as meningitis, encephalitis, or intracranial bleeding, can alter CSF composition and may influence glycine levels independent of inherited metabolic disease.
Interpretation differs in newborns, infants, and older individuals because brain development and metabolic demands vary. The clinical picture and other test results are essential for context.
References